Whitepaper:

Leveraging Machine Learning to Accelerate Drug Development

Download the new whitepaper from Grace to discover how CDMOs can apply machine learning to help get innovative treatments to patients quicker

Download the Whitepaper

With the potential to revolutionize drug development, machine learning can help pharmaceutical drug sponsors increase accuracy, reduce costs, speed time to market, improve product yield, and more. Partnering with a Contract Development and Manufacturing Organization (CDMO) that implements machine learning can expedite the lengthy drug development process, ultimately helping to bring novel treatments to patients more quickly.

Download the whitepaper and discover the ways one U.S.-based CDMO used machine learning to optimize a multi-step synthesis for a drug candidate and enhance analytical method development.

We’ve only just begun to scratch the surface of possibilities when it comes to artificial intelligence and machine learning applications in the drug development and manufacturing process. In this new whitepaper from Grace and Fierce Pharma, explore the ways machine learning can help:

Increase the accuracy and reproducibility of analytical testing
Improve yield and cycle time
Speed time to market by reducing timelines for process and analytical development
Introduce better impurity control
Reduce risk of delays in quality control

Download the Whitepaper